Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 202

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 202
---
 (including Governmental Entity), syndicate or other entity, whether or not having legal status.

“Person of Concern” has the meaning ascribed thereto in Section 1.1 of the Agreement.

“PFIC” means a Passive Foreign Investment Company.

“Plan of Arrangement” means the plan of arrangement to give effect to the Arrangement in the form attached as Annex E to
this Circular and Proxy Statement and any amendment or variation thereto made in accordance with its provisions or made at the direction of the Court in the Final Order.

129

“Proceeding” has the meaning ascribed thereto in Section 1.1 of the
Agreement.

“Proposed Amendments” has the meaning ascribed thereto in “Certain Canadian Federal Income Tax Considerations of the Arrangement” and “Certain Canadian Federal Income Tax Considerations of the Liquidation,” as applicable.

“Purchaser” means Xeno Acquisition Corp.

“QBCA” means the Business Corporations Act (Québec) and the regulations made thereunder.

“Record Date” means the close of business on November 21, 2025.

“Registered Shareholder” means a registered holder of Common Shares as recorded in the Shareholder register of the Company.

“Regulatory Approvals” has the meaning ascribed thereto in Section 1.1 of the Agreement.

“Representatives” means, collectively, any officer, director, employee, representative (including any financial or other
adviser) or agent of the Company or of any of its Subsidiaries.

“Required Shareholder Approval” means the approval of
the Arrangement Resolution of not less than (i) 66⁄% of the votes cast by Shareholders present in person (virtually) or represented by proxy at the Special
Meeting, and (ii) a majority of the votes cast by Shareholders present in person (virtually) or represented by proxy at the Special Meeting, excluding for this purpose the votes required to be excluded by MI
61-101, which excludes Common Shares held by related parties that are receiving a “collateral benefit” (as defined in MI 61-101) in connection with the
transaction. See “Canadian Securities Law Matters” for more information.

“Resident Dissenting Holder” has the meaning ascribed thereto in “Certain Canadian Federal Income Tax Considerations of the Arrangement.”

“Resident Holder” has the meaning ascribed thereto in “Certain Canadian Federal Income Tax Considerations of the Arrangement